InvestorsHub Logo
Followers 94
Posts 2355
Boards Moderated 0
Alias Born 11/07/2017

Re: SAMNOTSAMUEL post# 47788

Thursday, 02/14/2019 10:22:26 AM

Thursday, February 14, 2019 10:22:26 AM

Post# of 50157
SNS, unfortunately no news from Delcath regarding the clinical trials so reason no talk of medical side in my view.

Personally agree that under current CEO things are moving at a snails pace. Previous Phase III under Hobbes was much more efficient. Either qualifying cases are decreasing or enrollment rates are down on current Phase III as with number required they should have finished already by my estimates.

Last I heard 6 treatments is still the target rate but read somewhere that several patients had been pulled after just 2 treatments due to events. Will try to find the source and post if interested.

I think Chemosat is still showing significant improvement over alternative best care but can't say for sure as company being very quiet about anything to do with clinical trial.






Anything written herein that you find misspelled, objectionable, incoherent, dim-witted, plagiarized or legally actionable should be attributed to the keyboard Manufacturer, Russian Hackers, Jack Daniels (the drink not the person) or the DNC.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News